INSTRUCTIONS:

1. Entity Information:

Name of entity as on file with the Nevada Secretary of State:

Kintara Therapeutics, Inc.

Entity or Nevada Business Identification Number (NVID): E0341392009-0

2. Current Authorized Shares:

The current number of authorized shares and the par value, if any, of each class or series, if any, of shares before the change:

275,000,000 shares of common stock, par value $0.001 per share

3. Authorized Shares After Change:

The number of authorized shares and the par value, if any, of each class or series, if any, of

shares after the change:

5,500,000 shares of common stock, par value $0.001 per share

4. Issuance:

The number of shares of each affected class or series, if any, to be issued after the

change in exchange for each issued share of the same class or series:

One share of common stock will be issued after the split in exchange for every 50 shares of common stock held by each record holder immediately prior to the effective date and time.

5. Provisions:

The provisions, if any, for the issuance of fractional shares, or for the payment of money or the issuance of scrip to stockholders otherwise entitled to a fraction of a share and the percentage of outstanding shares affected thereby:

Fractional shares will be rounded up to the nearest whole share.

6. Provisions:

The required approval of the stockholders has been obtained.

7. Effective date and time: (Optional)

Date: 11/11/2022 Time: 5:00 p.m. Eastern

(must not be later than 90 days after the certificate is filed)

8. Signature:

(Required)

X /s/ Scott Praill CFO 11/10/2022

Signature of Officer Title Date